{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:16:03Z","timestamp":1790100963601,"version":"4.0.1"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T00:00:00Z","timestamp":1553212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0214240","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T13:26:16Z","timestamp":1553261176000},"page":"e0214240","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":67,"title":["Trends in polypharmacy and dispensed drugs among adults in the Netherlands as compared to the United States"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3116-787X","authenticated-orcid":true,"given":"Monika P.","family":"Oktora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Denig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens H. J.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina C. M.","family":"Schuiling-Veninga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eelko","family":"Hak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,3,22]]},"reference":[{"issue":"17","key":"ref1","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in Prescription Drug Use Among Adults in the United States From 1999\u20132012","volume":"314","author":"ED Kantor","year":"2015","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fphar.2018.00120","article-title":"Is Excessive Polypharmacy a Transient or Persistent Phenomenon? A Nationwide Cohort Study in Taiwan","volume":"9","author":"YJ Wang","year":"2018","journal-title":"Front Pharmacol"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1111\/jgs.15569","article-title":"Trends in Polypharmacy in Japan: A Nationwide Retrospective Study","volume":"66","author":"H Onoue","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6904-10-16","article-title":"Increasing polypharmacy\u2014an individual-based study of the Swedish population 2005\u20132008","volume":"10","author":"B Hovstadius","year":"2010","journal-title":"BMC Clin Pharmacol"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/pds.3947","article-title":"Increasing use of prescription drugs in the United Kingdom","volume":"25","author":"F Zhang","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008656","article-title":"Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study","volume":"5","author":"F Moriarty","year":"2015","journal-title":"BMJ Open"},{"issue":"9","key":"ref7","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00228-017-2288-1","article-title":"Determinants of change in polypharmacy status in Switzerland: the population-based CoLaus study","volume":"73","author":"N Abolhassani","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.amjopharm.2007.12.002","article-title":"Polypharmacy in elderly patients","volume":"5","author":"ER Hajjar","year":"2007","journal-title":"Am J Geriatr Pharmacother"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5455\/msm.2016.28.129-132","article-title":"Medication Adherence in Elderly with Polypharmacy Living at Home: a Systematic Review of Existing Studies","volume":"28","author":"E Zelko","year":"2016","journal-title":"Mater Sociomed"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00228-017-2276-5","article-title":"Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French population","volume":"73","author":"M Herr","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/dme.12497","article-title":"Polypharmacy in people with Type 1 and Type 2 diabetes is justified by current guidelines\u2014a comprehensive assessment of drug prescriptions in patients needing inpatient treatment for diabetes-associated problems","volume":"31","author":"S Bauer","year":"2014","journal-title":"Diabet Med"},{"key":"ref12","first-page":"1","article-title":"Primary care and prescription drugs: coverage, cost-sharing, and financial protection in six European countries","volume":"82","author":"S Thomson","year":"2010","journal-title":"Issue Brief (Commonw Fund)"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cger.2012.01.003","article-title":"Clinical practice guidelines for chronic diseases\u2014understanding and managing their contribution to polypharmacy","volume":"28","author":"RP Ruberu","year":"2012","journal-title":"Clin Geriatr Med"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/qshc.2004.012781","article-title":"Benefits and harms of direct to consumer advertising: a systematic review","volume":"14","author":"S Gilbody","year":"2005","journal-title":"Qual Saf Health Care"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1377\/hlthaff.2010.0862","article-title":"How health insurance design affects access to care and costs, by income, in eleven countries","volume":"29","author":"C Schoen","year":"2010","journal-title":"Health Aff (Millwood)"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1365-2125.2000.00166.x","article-title":"Dutch hospital drug formularies: pharmacotherapeutic variation and conservatism, but concurrence with national pharmacotherapeutic guidelines","volume":"49","author":"R Fijn","year":"2000","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/fampra\/cmr043","article-title":"Variation in formulary adherence in general practice over time (2003\u20132007)","volume":"28","author":"L van Dijk","year":"2011","journal-title":"Fam Pract"},{"key":"ref18","unstructured":"Stichting Farmaceutische Kengetallen (SFK). Facts and Figures 2014 on pharmaceutical care in The Netherlands. 2014; Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.sfk.nl\/english\/Dataenfeiten2014_A4_magazine_web.pdf\" xlink:type=\"simple\">https:\/\/www.sfk.nl\/english\/Dataenfeiten2014_A4_magazine_web.pdf<\/ext-link>. Accessed 07, 2018."},{"key":"ref19","article-title":"Sterke toename aantal polyfarmacie pati\u00ebnten","year":"2016","journal-title":"Pharmaceutisch Weekblad"},{"issue":"7","key":"ref20","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1136\/annrheumdis-2013-204641","article-title":"Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register","volume":"74","author":"MH Otten","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00228-014-1803-x","article-title":"Prescription and indication trends of antidepressant drugs in the Netherlands between 1996 and 2012: a dynamic population-based study","volume":"71","author":"R Noordam","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"e51860","DOI":"10.1371\/journal.pone.0051860","article-title":"Trends in antibiotic prescribing in adults in Dutch general practice","volume":"7","author":"MB Haeseker","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing","volume":"175","author":"IA Scott","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/erp.13.20","article-title":"The population-based prescription database IADB.nl: its development, usefulness in outcomes research and challenges","volume":"13","author":"ST Visser","year":"2013","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"ref25","unstructured":"whocc.no [Internet]. WHO Collaborating Centre for Drug Statistics Methodology. Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.whocc.no\/atc_ddd_index\/\" xlink:type=\"simple\">https:\/\/www.whocc.no\/atc_ddd_index\/<\/ext-link>. Accessed April-May, 2016."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2147\/CLEP.S163037","article-title":"Concordance assessment of self-reported medication use in the Netherlands three-generation Lifelines Cohort study with the pharmacy database iaDB.nl: The PharmLines initiative","volume":"10","author":"R Sediq","year":"2018","journal-title":"Clin Epidemiol"},{"key":"ref27","unstructured":"Nederlands Huisartsen Genootschap (NHG), Nederlandse Vereniging voor Klinische Geriatrie (NVKG), Orde van Medisch Specialisten (OMS). Multidisciplinaire Richtlijn Polyfarmacie bij ouderen 2012. Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.nhg.org\/sites\/default\/files\/content\/nhg_org\/uploads\/polyfarmacie_bij_ouderen.pdf\" xlink:type=\"simple\">https:\/\/www.nhg.org\/sites\/default\/files\/content\/nhg_org\/uploads\/polyfarmacie_bij_ouderen.pdf<\/ext-link>. Accessed 07\/22, 2018."},{"key":"ref28","unstructured":"Hoeve C, Denig P, Taxis K, Schuiling-Veninga C. Development of algorithms to identify polypharmacy patients in need of a medication review. M.Sc. Thesis, University of Groningen. 2015."},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJM198007173030304","article-title":"Aging, natural death, and the compression of morbidity","volume":"303","author":"JF Fries","year":"1980","journal-title":"N Engl J Med"},{"key":"ref30","unstructured":"oecd.org [internet] OECD Health Statistics 2014. How does the Netherlands compare? Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.oecd.org\/els\/health-systems\/Briefing-Note-NETHERLANDS-2014.pdf\" xlink:type=\"simple\">http:\/\/www.oecd.org\/els\/health-systems\/Briefing-Note-NETHERLANDS-2014.pdf<\/ext-link>. Accessed 2018, April."},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1517\/14740338.2013.827660","article-title":"Clinical consequences of polypharmacy in elderly","volume":"13","author":"RL Maher","year":"2014","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.healthpol.2012.09.005","article-title":"The impact of increasing polypharmacy on prescribed drug expenditure-a register-based study in Sweden 2005\u20132009","volume":"109","author":"B Hovstadius","year":"2013","journal-title":"Health Policy"},{"key":"ref33","article-title":"Behandeling van gastro-oesofageale reflux en dyspepsie met H2-receptorblokkerende geneesmiddelen en protonpompremmers","author":"M van der Linden","year":"2009","journal-title":"Behandeling van gastro-oesofageale reflux en dyspepsie met H2-receptorblokkerende geneesmiddelen en protonpompremmers"},{"key":"ref34","article-title":"NHG-Standaard Maagklachten (derde herziening)","author":"ME Numans","year":"2013","journal-title":"Huisarts Wet 26\u201335"},{"key":"ref35","unstructured":"Nederlands Huisartsen Genootschap (NHG). Cardiovasculair risicomanagement. 2012; Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.nhg.org\/standaarden\/volledig\/cardiovasculair-risicomanagement\" xlink:type=\"simple\">https:\/\/www.nhg.org\/standaarden\/volledig\/cardiovasculair-risicomanagement<\/ext-link>. Accessed 22\/7, 2018."},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00149831-200308000-00004","article-title":"European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts)","volume":"10","author":"G De Backer","year":"2003","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/0272989X06286479","article-title":"Toward targeted hypertension screening guidelines","volume":"26","author":"S van Buuren","year":"2006","journal-title":"Med Decis Making"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1185\/030079905X46368","article-title":"Management of hypertension and hypercholesterolaemia in primary care in The Netherlands","volume":"21","author":"JT van Wyk","year":"2005","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"ref39","first-page":"169","article-title":"Clinical practice guideline for cardiovascular risk management in the Netherlands","volume":"66","author":"YM Smulders","year":"2008","journal-title":"Neth J Med"},{"issue":"621","key":"ref40","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.3399\/bjgp14X677815","article-title":"High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: a population-based cross-sectional study","volume":"64","author":"AR Koffeman","year":"2014","journal-title":"Br J Gen Pract"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/eurpub\/ckq187","article-title":"The burden of 2009 pandemic influenza A(H1N1) in the Netherlands","volume":"22","author":"CC Wielders","year":"2012","journal-title":"Eur J Public Health"},{"issue":"7536","key":"ref42","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/bmj.332.7536.248","article-title":"Antibiotics in pandemic flu","volume":"332","author":"MJ Bonten","year":"2006","journal-title":"BMJ"},{"key":"ref43","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial Consumption Database (ESAC-Net). 2017; Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/ecdc.europa.eu\/en\/antimicrobial-consumption\/surveillance-and-disease-data\/database\" xlink:type=\"simple\">https:\/\/ecdc.europa.eu\/en\/antimicrobial-consumption\/surveillance-and-disease-data\/database<\/ext-link>. Accessed 01\/07, 2019."},{"key":"ref44","unstructured":"World Health Organization. European strategic action plan on antibiotic resistance. 2011 10 June 2011;EUR\/RC61\/14."},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1377\/hlthaff.27.1.58","article-title":"Measuring the health of nations: updating an earlier analysis","volume":"27","author":"E Nolte","year":"2008","journal-title":"Health Aff (Millwood)"},{"key":"ref46","unstructured":"OECD. Health at a Glance 2017: OECD Indicators. 2017; Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1787\/health_glance-2017-en\" xlink:type=\"simple\">http:\/\/dx.doi.org\/10.1787\/health_glance-2017-en<\/ext-link>. Accessed 07, 2018."},{"key":"ref47","first-page":"7","article-title":"Halvering groei aantal polyfarmaciepati\u00ebnten","volume":"12","year":"2018","journal-title":"Pharmaceutisch Weekblad 12"},{"issue":"9","key":"ref48","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2165\/00002512-200522090-00005","article-title":"Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause","volume":"22","author":"MC Passarelli","year":"2005","journal-title":"Drugs Aging"},{"key":"ref49","article-title":"Inappropriate medication use and risk of falls\u2014a prospective study in a large community-dwelling elderly cohort","author":"S Berdot","year":"2009","journal-title":"BMC Geriatr"},{"issue":"11","key":"ref50","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2165\/11316750-000000000-00000","article-title":"Medication-related admissions in older people: a cross-sectional, observational study","volume":"26","author":"S Rogers","year":"2009","journal-title":"Drugs Aging"},{"issue":"5","key":"ref51","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2337\/dc13-1861","article-title":"Potential overtreatment and undertreatment of diabetes in different patient age groups in primary care after the introduction of performance measures","volume":"37","author":"ST de Vries","year":"2014","journal-title":"Diabetes Care"},{"issue":"2","key":"ref52","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamainternmed.2015.7927","article-title":"Adverse Effects Associated With Proton Pump Inhibitors","volume":"176","author":"AJ Schoenfeld","year":"2016","journal-title":"JAMA Intern Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0214240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:41:48Z","timestamp":1588966908000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0214240"}},"subtitle":[],"editor":[{"given":"Juan F.","family":"Orueta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,3,22]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0214240","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,22]]}}}